![Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire](https://mms.businesswire.com/media/20180923005029/en/627351/23/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.gustaveroussy.fr/sites/default/files/cppartenariat-fresh-share-180923.png)
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
![Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition | Inside Precision Medicine Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition | Inside Precision Medicine](https://www.insideprecisionmedicine.com/wp-content/uploads/2020/06/au_foundationmedicine307812-768x300.jpg)
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition | Inside Precision Medicine
92. Phil Stephens, Ph.D., CSO, Foundation Medicine- Session: Liquid Biopsy – Using the Right Tool for the Right Job on Vimeo
![Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News](https://medcitynews.com/uploads/2016/11/GettyImages-536098868.jpg)
Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval - MedCity News
![Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35245-x/MediaObjects/41467_2022_35245_Fig1_HTML.png)